SCHEMBL9130854

SCHEMBL9130854

CC1C[C]1c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
NISCH Q9Y2I1 1/20 0.39
ACHE P22303 1/20 0.37
RAB9A P51151 1/20 0.36
MAOB P27338 2/20 0.35
MAOA P21397 1/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35
SLC22A3 O75751 1/20 0.35
SLC6A4 P31645 1/20 0.35
KMT2A Q03164 1/20 0.34
NOS1 P29475 2/20 0.34
NOS2 P35228 2/20 0.34
HTR1D P28221 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
HTR3A P46098 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28431861 1.00 ALDH1A1 (0.42) ALDH1A1NISCHACHERAB9AMAOB
SCHEMBL2537581 0.79 ALDH1A1 (0.38) ALDH1A1NISCHMAOBMAOA
SCHEMBL28911580 0.75 HRH3 (0.46) ALDH1A1MAOBMAOA
SCHEMBL145371 0.74 MAOB (0.44) ALDH1A1MAOBMAOAHTR2CKDM1A
SCHEMBL5534036 0.74 HRH2 (0.41) ALDH1A1MAOBMAOAKMT2ANOS1
SCHEMBL14974371 0.72 ALDH1A1 (0.42) ALDH1A1RAB9AMAOBKDM1A
SCHEMBL695560 0.72 ALDH1A1 (0.42) ALDH1A1NISCHRAB9AMAOBKDM1A
SCHEMBL17652437 0.72 ALDH1A1 (0.42) ALDH1A1RAB9AMAOBMAOAKDM1A
SCHEMBL21525 0.70 ALDH1A1 (0.35) ALDH1A1NISCHMAOBMAOASLC22A2
SCHEMBL14697788 0.70 MAOB (0.35) ALDH1A1ACHEMAOBMAOAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102300550-A Perfume systems 2011-12-28 CN claimed
WO-2017027312-A1 GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2017-02-16 WO disclosed
US-5385906-A Treating gramnegative and grampositive bacterial infections THE UPJOHN COMPANY (US) 1995-01-31 US disclosed
US-5262417-A Antibacterial quinolone compounds THE UPJOHN COMPANY (US) 1993-11-16 US disclosed
EP-0447484-A1 ANTIBACTERIAL QUINOLONE COMPOUNDS THE UPJOHN COMPANY (US) 1991-09-25 EP disclosed
WO-1990006307-A2 ANTIBACTERIAL QUINOLONE COMPOUNDS THE UPJOHN COMPANY (US) 1990-06-14 WO disclosed
US-4433248-A Charged aerosol wind/electric power generator with solar and/or gravitational regeneration MARKS ALVIN M 1984-02-21 US disclosed